1 Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
2 Standard Chemotherapy + Mitazalimab, More Than 90% Effective In The Treatment Of Pancreatic Cancer! Oct 10, 2024
3 Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd Sep 05, 2024
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 03, 2024
Read More Apparatus The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma! Nov 04, 2024
